Concepedia
Statistics
Publications
15
Citations
975
H-Index
14
Active since
2006
Affiliations
Gene Therapy Laboratory(Current)
Leeds Teaching Hospitals NHS Trust
WuXi AppTec (China)
Seagen (United States)
University of British Columbia
Jeffrey Lau is an author at Gene Therapy Laboratory specializing in pharmacy, antibody-drug conjugates, and antibody conjugation.
Publications per year
2006–2023
Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma
David Dornan, Fiona Bennett, Yvonne Chen et al. · Blood · 2009 · 271 citations · Full text
Pharmacy, Oncology, Pharmacology +17
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance
Thijs J. Hagenbeek, Marc Hafner, Rana Mroue et al. · Nature Cancer · 2023 · 195 citations · Full text
Life Sciences, Medicinal Chemistry, Oncology +17
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma
Andrew G. Polson, Marna Williams, Aimee Gray et al. · Leukemia · 2010 · 88 citations
Pharmacy, Medicinal Chemistry, Oncology +14
DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
Dongwei Li, Kirsten Achilles Poon, Shang‐Fan Yu et al. · Molecular Cancer Therapeutics · 2013 · 85 citations
Pharmacy, Oncology, Pharmacokinetics +17
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody–Drug Conjugates with Self-Immolative Disulfide Linkers
Thomas H. Pillow, Melissa M. Schutten, Shang‐Fan Yu et al. · Molecular Cancer Therapeutics · 2017 · 69 citations
Pharmacy, Medicinal Chemistry, Pharmacology +17
1–5 of 15